A detailed history of Kbc Group Nv transactions in Rx Sight, Inc. stock. As of the latest transaction made, Kbc Group Nv holds 1,232 shares of RXST stock, worth $55,230. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,232
Previous 753 63.61%
Holding current value
$55,230
Previous $45,000 35.56%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$40.78 - $57.04 $19,533 - $27,322
479 Added 63.61%
1,232 $61,000
Q2 2024

Jul 17, 2024

BUY
$50.42 - $64.29 $37,966 - $48,410
753 New
753 $45,000

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $1.24B
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Kbc Group Nv Portfolio

Follow Kbc Group Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.